|
DSGN Design Therapeutics Inc 1807120 |
| Balance Sheet |
|
Current Assets
|
257,242,000 |
|
Assets
|
261,629,000 |
|
Current Liabilities
|
7,432,000 |
|
Liabilities
|
9,176,000 |
|
Equity
|
252,453,000 |
|
Shares Out
|
56,621,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-33,245,000 |
|
Investing Cash Flow
|
42,123,000 |
| Market Analysis |
Market Cap
|
330,097,627 |
|
Price
|
5.06 |
|
BVPS
|
4.46 |
|
PB
|
1.14 |
|
EPS
|
-0.90 |
|
PS
|
7.86 |
|
FCF
|
8,878,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view DSGN documents filed with the SEC.
DSGN Filings
Clear
